1. Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals

   • Joseph Ongrádi
   • Dharam V. Ablashi
   • Masao Ogata

   Review Open access 18 August 2016 Pages: 1 - 19

2. Review of functional MRI in HIV: effects of aging and medication

   • C. S. Hakkers
   • J. E. Arends
   • M. Vink

   Review Open access 07 October 2016 Pages: 20 - 32

   

3. Development and characterization of a human microglia cell model of HIV-1 infection

   • Pratima Rawat
   • Stephen A. Spector

   OriginalPaper 18 August 2016 Pages: 33 - 46

   

4. Immortalization of primary microglia: a new platform to study HIV regulation in the central nervous system

   • Yoelvis Garcia-Mesa
   • Taylor R. Jay
   • David Alvarez-Carbonell

   OriginalPaper Open access 21 November 2016 Pages: 47 - 66

   

5. Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining “symptomatic” versus “asymptomatic” HAND

   • Lisa C. Obermeit
   • Jessica Beltran
   • The CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) Group

   OriginalPaper 24 August 2016 Pages: 67 - 78

   

6. Human cytomegalovirus downregulates SLITRK6 expression through IE2

   • Huanan Liao
   • Haruna Sato
   • Hiroyuki Nakamura

   OriginalPaper 16 August 2016 Pages: 79 - 86

   

7. Selective developmental alterations in The HIV-1 transgenic rat: Opportunities for diagnosis of pediatric HIV-1

   • Kristen A. McLaurin
   • Rosemarie M. Booze
   • Charles F. Mactutus

   OriginalPaper 18 August 2016 Pages: 87 - 98

   

8. JC virus infection is acquired very early in life: evidence from a longitudinal serological study

   • Francesca Elia
   • Sonia Villani
   • Serena Delbue

   OriginalPaper 18 August 2016 Pages: 99 - 105

   

9. Cerebrospinal fluid interferon alpha levels correlate with neurocognitive impairment in ambulatory HIV-Infected individuals

   • Albert M. Anderson
   • Jeffrey L. Lennox
   • William R. Tyor

   OriginalPaper 11 July 2016 Pages: 106 - 112

   

10. Specific amino acids in HIV-1 Vpr are significantly associated with differences in patient neurocognitive status

    • Will Dampier
    • Gregory C. Antell
    • Fred C. Krebs

    OriginalPaper 11 July 2016 Pages: 113 - 124

    

11. Long-term follow-up of HTLV-1 proviral load in asymptomatic carriers and in incident cases of HAM/TSP: what is its relevance as a prognostic marker for neurologic disease?

    • Marina Lobato Martins
    • Jacqueline Cronemberger Guimarães
    • Anna Bárbara de Freitas Carneiro-Proietti

    OriginalPaper 27 September 2016 Pages: 125 - 133

    

12. Evaluation of practice effect on neuropsychological measures among persons with and without HIV infection in northern India

    • Raymond L. Ownby
    • Drenna Waldrop-Valverde
    • Mahendra Kumar

    OriginalPaper 13 October 2016 Pages: 134 - 140

    

13. JC virus granule cell neuronopathy in the setting of chronic lymphopenia treated with recombinant interleukin-7

    • David N. Soleimani-Meigooni
    • Katherine E. Schwetye
    • Robert C. Bucelli

    Short Communication 15 July 2016 Pages: 141 - 146

    

14. HIV and decreased risk of multiple sclerosis: role of low CD4+ lymphocyte count and male prevalence

    • Tatiana Koudriavtseva
    • Domenico Plantone
    • Fulvia Pimpinelli

    Short Communication 18 July 2016 Pages: 147 - 151

    

15. Induction of varicella zoster virus DNA replication in dissociated human trigeminal ganglia

    • Randall J. Cohrs
    • Hussain Badani
    • Don Gilden

    Short Communication 28 September 2016 Pages: 152 - 157

    

16. Adult-onset opsoclonus-myoclonus syndrome due to West Nile Virus treated with intravenous immunoglobulin

    • Julien Hébert
    • David Armstrong
    • James Perry

    Case Report 29 July 2016 Pages: 158 - 159

17. Atypical presentations of acute disseminated encephalomyelitis (ADEM) in HIV infection

    • Ansuya Naidoo
    • Hoosain Paruk
    • Anand Moodley

    clinical report 29 September 2016 Pages: 160 - 170